var text = [{"boxId":"1","infoText":"Management of severe AS<sup>a<\/sup>","boxType":BoxTypes.ACTIVITY_STARTING_POINT,"nextBox":"2"},{"boxId":"2","infoText":"Symptoms","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"3"},{"text":"Yes","eventAction":"10"}]},{"boxId":"3","infoText":"LVEF &lt;50%","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"4"},{"text":"Yes","eventAction":"5"}]},{"boxId":"4","infoText":"Physically active","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"6"},{"text":"Yes","eventAction":"8"}]},{"boxId":"5","infoText":"SAVR","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"6","infoText":"Presence of risk factors<sup>b<\/sup> and low individual surgical risk","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"7"},{"text":"Yes","eventAction":"5"}]},{"boxId":"7","infoText":"Re-evaluate in 6 months or when symptoms occur","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"8","infoText":"Exercise Test","boxType":BoxTypes.ACTIVITY_GOING_THROUGH,"nextBox":"9"},{"boxId":"9","infoText":"Symptoms or fall in blood pressure below baseline","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"6"},{"text":"Yes","eventAction":"5"}]},{"boxId":"10","infoText":"Absence of comorbidity or general condition that make benefit unlikely","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"11"},{"text":"Yes","eventAction":"12"}]},{"boxId":"11","infoText":"Medical therapy","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"12","infoText":"Low-risk and no other characteristics that favour TAVI<sup>c<\/sup>","boxType":BoxTypes.DECISION_GOING_THROUGH,"buttons":[{"text":"No","eventAction":"13"},{"text":"Yes","eventAction":"5"}]},{"boxId":"13","infoText":"Careful individual evaluation of technical suitability and risk-benefit ratio of intervention modes by the Heart Team<sup>c<\/sup>","boxType":BoxTypes.ACTIVITY_GOING_THROUGH,"nextBox":"14"},{"boxId":"14","infoText":"SAVR or TAVI","boxType":BoxTypes.ACTIVITY_EXIT_BOX},{"boxId":"998","boxType":BoxTypes.FOOTER,"hasFootnote":true,"referenceText":"<sup>a<\/sup>See <a href=\"ref_ENAS5328_6.2.2.0.html\">Figure 2</a> and <a href=\"ref_ENAS5328_6.2.3.0.html\">Table 6</a> for the definition of severe AS.<br><sup>b<\/sup>Surgery should be considered (IIa C) if one of the following is present: peak velocity &gt;5.5 m\/s; severe valve calcification + peak velocity progression ≥0.3 m\/s per year; markedly elevated neurohormones (&gt;threefold age- and sex-corrected normal range) without other explanation; severe pulmonary hypertension (systolic pulmonary artery pressure &gt;60 mmHg).<br><sup>c<\/sup>See <a href=\"ref_ENAS5328_6.3.3.0.html\">Table 7</a> and <a href=\"ref_ENAS5328_6.3.1.0.html\">Table of Recommendations in section 5.2</a> Indications for intervention in aortic stenosis.","hasAbbreviation":true,"abbreviationText":"AS = aortic stenosis; LVEF = left ventricular ejection fraction; SAVR = surgical aortic valve replacement; TAVI = transcatheter aortic valve implantation","staticImageName":"interactive_0001437","extraButtons":[{"buttonRow":[{"text":"Abbreviation(s) and Footnote(s) ","buttonId":FooterButtons.REF_BUTTON},{"image":"Flip PDF","buttonId":FooterButtons.PDF_BUTTON}]},{"buttonRow":[{"text":"Reset","buttonId":FooterButtons.RESET_BUTTON},{"text":"<a class='more-info-link' href='ref_ENAS5328_6.3.2.0.html'>More Information</a>","buttonId":FooterButtons.MORE_INFO_BUTTON}]}]}];